Gv. Papatheodoridis et al., CLINICOPATHOLOGICAL ASSESSMENT OF HEPATITIS-C VIRUS-INFECTION IN PARENTERAL DRUG-ABUSERS, The American journal of gastroenterology, 90(10), 1995, pp. 1843-1846
To determine the severity of hepatic histological lesions in anti-HCV
positive parenteral drug abusers and to correlate it with the level of
ALT activity and HCV RNA determined by polymerase chain reaction (PCR
). Methods: Twenty-nine of the 62 anti-HCV-positive parenteral drug ab
users who consecutively entered a Rehabilitation Center of Athens cons
ented to liver biopsy and were prospectively and thoroughly followed u
p for a mean of 12.9 (range 6-33) months, Anti-HCV was detected by a s
econd-generation enzyme immunoassay and confirmed by a second-generati
on recombinant inmunoblot assay, Serum samples were tested for HCV RNA
by nested PCR with primers from the highly conserved 5' untranslated
region of the HCV genome, Results: Liver biopsy revealed lesions compa
tible with chronic hepatitis in 26 (89.6%) and a normal liver in three
(10.4%) of the 29 patients. In particular, 11 (37.9%) had minimal and
15 (57.1%) had mild chronic hepatitis; fibrosis was absent or mild in
all cases, Histological grade and stage were significantly milder in
patients with persistently normal ALT activity than in those with incr
eased ALT activity, However, chronic hepatitis was observed in five (6
2.5%) of the eight patients with normal ALT levels, The presence of se
rum HCV RNA was not significantly correlated with the severity of hist
ological lesions, HCV RNA was detected in 16 (57.1%) of the 28 cases t
ested, In particular, HCV RNA was detected in one (33.3%) of the three
cases with normal liver and in three (37.5%) of the eight patients wi
th normal ALT levels, Conclusions: Liver biopsy appears to be the meth
od of choice for the accurate evaluation of anti-HCV positive parenter
al drug abusers, irrespective of ALT activity and presence of serum HC
V RNA, Chronic hepatitis is observed in the majority and the state of
''healthy'' carrier of HCV in the minority of this epidemiological set
ting.